Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Time on Our Side

Despite a number of technical obstacles, fragment screening is gradually gaining in popularity particularly in the wake of recent advances in dynamic injection methods. Eric Reese from SensiQ Technologies reports.

Eric Reese, SensiQ Technologies (September 2014)

Keywords: Fragment-based drug design, Surface plasmon resonance, Low-affinity compounds, Injection techniques, Actives selection

    View full article    |    Back to Discovery Technology section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |